HSBC’s Largest Shareholder Stresses On Asia Business Spinoff To Boost Market Values: Report
HSBC Holdings Plc’s (NYSE: HSBC) top shareholder, Ping An Insurance Group Co, isn’t convinced by pushback on HSBC’s spinoff of its Asia operations. The shareholder argues that HSBC requires urgent and radical change, Bloomberg reported citing a person familiar with its views. The report says that Ping An estimates the spinoff would generate an additional market value of $25-$35 […]
Oregon Psilocybin Services Act: State Vs. Local Decisions, The Ultimate ‘Opt-Out’ Choice
Oregon’s elected councilors in Philomath joined the debate on whether to offer their voters to “opt out” of Measure 109, the state-wide legalization project for the use of medical psilocybin. The legislation is set to begin ruling as of January 2023 and would make Oregon the first state to allow lawful psilocybin use, under specific conditions. […]
Have We Seen The Beginning Of The End Of Data Privacy In The European Union?
With the goal of protecting the European Union (EU) from child pornographers and other unsavory and illegal activity, the Digital Services Act, a regulatory act aimed at making the internet a safer place, is on its way to cracking down on Big Tech. Big Tech Could Be Facing Big Fines If Companies Don’t Comply Beginning […]
TC BioPharm Says It Aims To Deliver A Big Breakthrough In Cancer Treatments
Approximately 1.7 million new cancer cases are reported every year in the United States. As the nation’s second leading cause of death after heart disease, there are around 600,000 cancer-related deaths each year. While those numbers look grim, medical breakthroughs in the past decades have made a huge impact, bringing mortality rates down 27% from […]
Learn About Latest Petition To Reschedule Magic Mushrooms In The UK
A new public appeal, launched just days ago, aims at moving psilocybin from Schedule 1 to Schedule 2 of UK’s Misuse of Drugs 2001 legislation. As all regulations, it determines the legal circumstances for possession, supply, production, export and import of the listed (so called “controlled”) drugs. The authorized scope depends on the assigned schedule, ranging […]
Pfizer, Global Blood Therapeutics In Advanced Talks For $5B Buyout Deal: Report
Pfizer Inc (NYSE: PFE) is reportedly in advanced talks to buy Global Blood Therapeutics Inc (NASDAQ: GBT) for about $5 billion, bolster its portfolio and pipeline. Global Blood Therapeutics markets sickle-cell disease treatment, Oxbryta, which generated $194.7 million in revenue in 2021. Read More
India Based Pharma Companies In Race To Buy Athenex, Shares Surge
Athenex Inc (NASDAQ: ATNX) shares climbed during the after-hours session as India’s Intas Pharmaceuticals and Dr Reddy’s Laboratories Ltd (NYSE: RDY) are reportedly in talks to acquire Athenex. According to the Economic Times report, the deal could be valued at $200-250 million as the U.S.-based biotechnology firm looks to sell a controlling stake. The two Indian pharma companies are competing with […]
CBOE’s Weekly Market Recap: July 18 To 22
Following last week’s price movements on the SPDR S&P 500 ETF Trust (NYSEARCA: SPY), it appears that July may be the first month to close with a price ascension of over 1% since March. While macroeconomic data seems to suggest that the American economy is still in a recession, several indices show price ascension that […]
Will This Cannabis Company Also Become A Psilocybin Producer And Facilitator? Here’s What They’re Thinking
Kaya Holdings Inc., (OTCQB: KAYS), also known as “KAYS,” holder and operator of U.S cannabis licenses in all plant-touching categories, initiated the process of seeking the requisite licenses to manufacture psilocybin and set up facilitation service centers in Oregon. As a reminder, the state was the first to legalize the use of psychedelics for mental health treatments in […]
Which Broker/Investment Bank Could Be Purchased Next, Following $1.3B Cowen/TD Deal?
The latest bank/investment firm M&A came on Tuesday as Toronto-Dominion Bank (NYSE: TD) bought Cowen Inc (NASDAQ: COWN) in an all cash deal valued at $1.3 billion or $39 per share, according to a TD Bank Group press release. TD believes that “through this transaction, TD Securities will accelerate its long-term growth strategy in the United […]